Econazole nitrate Calcium Channel modulator

Cat.No.S2535

Econazole Nitrate (NSC 243115,Spectazole) is a Ca2+ channel blocker, used as an antifungal medicine that fights infections caused by fungus.
Econazole nitrate  Calcium Channel modulator Chemical Structure

Chemical Structure

Molecular Weight: 444.7

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 444.7 Formula

C18H15Cl3N2O.HNO3

Storage (From the date of receipt)
CAS No. 24169-02-6 Download SDF Storage of Stock Solutions

Synonyms NSC 243115,Spectazole Smiles C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-]

Solubility

In vitro
Batch:

DMSO : 89 mg/mL ( (200.13 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
Calcium channel [1]
In vitro

Econazole nitrate is an effective inducer of micronuclei over a narrow dose range in cell lines V79, XEM2 and XEMd-MZ (expresses CYP1A2). [1] This compound inhibits the proliferation of MCF-7 cells in a time- and dose-dependent manner by MTT method and colony forming assay. This compound results in typical characteristics of apoptosis including the morphological changes and DNA fragmentation in MCF-7 cells. This compound results in the decrease expression of procaspase-3, procaspase-9 and bcl-2. [2] This compound inhibits ADP-ribose-activated currents in HEK-293 cells expressing recombinant human TRPM2 (hTRPM2). This compound produces an essentially complete inhibition of the TRPM2-mediated current. [3] This compound (25-50 mM) partially inhibits capacitative Ca2+ entry induced by cyclopiazonic acid, another endoplasmic reticulum Ca2+ pump inhibitor. This compound induces Ca2+ influx via two separate pathways: one is sensitive to La3+, the other is not. [4] This compound reversibly inhibits (Bu)(2)cAMP-stimulated progesterone production in a dose- and time-dependent manner in MA-10 cells without affecting total protein synthesis or P450(scc) and 3beta-hydroxysteroid dehydrogenase (3beta-HSD) enzyme expression or activity. [5] This compound is a store-operated Ca2+ channel antagonist which induces cytotoxic cell death of leukemia. This compound (5-20 mM) arrests human colon cancer cells at the G0/G1 phase of the cell cycle. This compound induces COLO 205 cells apoptosis evidenced by ladder formation in DNA fragmentation assay and sub-G1 peak. [6]

References
  • https://pubmed.ncbi.nlm.nih.gov/9990306/
  • https://pubmed.ncbi.nlm.nih.gov/11282276/
  • https://pubmed.ncbi.nlm.nih.gov/15919146/

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01696799 Completed
Interdigital Tinea Pedis
AmDerma|AmDerma Pharmaceuticals LLC
September 2011 Phase 2

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map